{"id":66900,"date":"2026-05-07T14:25:18","date_gmt":"2026-05-07T08:55:18","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=66900"},"modified":"2026-05-07T14:25:20","modified_gmt":"2026-05-07T08:55:20","slug":"prosthetic-valve-choice-a-lifetime-strategy","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/","title":{"rendered":"Prosthetic Valve Choice: A Lifetime Strategy"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/i-0gRSkbR9A?si=FrKYdMCtikMQVGro\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">The choice between a mechanical and a bioprosthetic valve is increasingly viewed through the lens of &#8220;lifetime management,&#8221; shifting away from a simple age-based binary toward a more nuanced assessment of patient longevity, lifestyle, and the feasibility of future interventions. Current guidelines emphasize shared decision-making, but several objective clinical pillars remain central to the selection process.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Mechanical Prostheses<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Mechanical valves are generally favored when durability is the primary concern and the patient can safely manage long-term anticoagulation.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Durability:<\/strong> Virtually lifelong; the risk of structural valve deterioration (SVD) is negligible.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/www.acc.org\/latest-in-cardiology\/ten-points-to-remember\/2020\/12\/16\/22\/01\/2020-acc-aha-vhd-gl-pt-3-gl-vhd\" type=\"link\" id=\"https:\/\/www.acc.org\/latest-in-cardiology\/ten-points-to-remember\/2020\/12\/16\/22\/01\/2020-acc-aha-vhd-gl-pt-3-gl-vhd\">Anticoagulation<\/a>:<\/strong> Requires lifelong Vitamin K Antagonists (VKA), usually with a target INR of <strong>2.0\u20133.0<\/strong> for aortic positions and <strong>2.5\u20133.5<\/strong> for mitral positions.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2020.11.018\" type=\"link\" id=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2020.11.018\">Ideal Candidate<\/a>:<\/strong>\n<ul class=\"wp-block-list\">\n<li class=\"\">Patients aged <strong>&lt;50<\/strong> (Aortic) or <strong>&lt;55<\/strong> (Mitral).<\/li>\n\n\n\n<li class=\"\">Patients already on anticoagulation for other reasons (e.g., Atrial Fibrillation).<\/li>\n\n\n\n<li class=\"\">Patients with a high risk of rapid bioprosthetic calcification (e.g., end-stage renal disease or hyperparathyroidism).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">According to a comparative study published in <em><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29117490\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29117490\/\">NEJM<\/a><\/em> in 2017, long-term mortality benefit associated with a mechanical prosthesis, as compared with a biologic prosthesis, persisted until 70 years of age among patients undergoing mitral-valve replacement and until 55 years of age among those undergoing aortic-valve replacement.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. Bioprosthetic (Tissue) Valves<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bioprosthetic valves are selected to avoid the lifestyle constraints and bleeding risks associated with warfarin, acknowledging that a re-intervention will likely be necessary.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Durability:<\/strong> Limited by <a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/circulationaha.117.030729\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/circulationaha.117.030729\">Structural Valve Degeneration<\/a> (SVD), which typically occurs <strong>10\u201315 years<\/strong> post-implantation, though newer generation valves may offer improved longevity.<\/li>\n\n\n\n<li class=\"\"><strong>Anticoagulation:<\/strong> Only required for the first <strong>3\u20136 months<\/strong> post-operatively (aspirin or VKA), unless other indications exist.<\/li>\n\n\n\n<li class=\"\"><strong>Ideal Candidate:<\/strong>\n<ul class=\"wp-block-list\">\n<li class=\"\">Patients aged <strong>>65\u201370<\/strong>.<\/li>\n\n\n\n<li class=\"\">Patients with contraindications to long-term anticoagulation or high bleeding risk.<\/li>\n\n\n\n<li class=\"\">Women planning pregnancy (to avoid the teratogenicity of warfarin).<\/li>\n\n\n\n<li class=\"\">Patients whose lifestyle or occupation makes anticoagulation dangerous (e.g., contact sports, manual labor).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">3. The &#8220;Gray Zone&#8221; and Lifetime Strategy<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">For patients aged <strong>50 to 65<\/strong>, the decision is highly individualized. The focus has shifted toward the <strong>&#8220;Valve-in-Valve&#8221; (ViV)<\/strong> potential.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Aortic Position:<\/strong> If a bioprosthesis is chosen in a younger patient, the surgeon must consider the <strong>sinus of Valsalva<\/strong> anatomy and <strong>coronary height<\/strong> to ensure a future TAVI (Transcatheter Aortic Valve Implantation) is technically feasible.<\/li>\n\n\n\n<li class=\"\"><strong>Small Annulus:<\/strong> In patients with a small aortic root, a mechanical valve or a root enlargement procedure may be preferred to avoid <strong>Prosthesis-Patient Mismatch (PPM)<\/strong>, which significantly impacts long-term survival.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">4. Summary of Clinical Considerations<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Factor<\/strong><\/td><td><strong>Mechanical<\/strong><\/td><td><strong>Bioprosthetic<\/strong><\/td><\/tr><\/thead><tbody><tr><td><strong>Durability<\/strong><\/td><td>Excellent (&gt;25+ years)<\/td><td>Limited (10\u201315 years)<\/td><\/tr><tr><td><strong>Thromboembolism<\/strong><\/td><td>Higher risk<\/td><td>Lower risk<\/td><\/tr><tr><td><strong>Anticoagulation<\/strong><\/td><td>Lifelong Warfarin (INR monitoring)<\/td><td>Short-term or None<\/td><\/tr><tr><td><strong>Re-operation<\/strong><\/td><td>Rare<\/td><td>Likely in younger patients<\/td><\/tr><tr><td><strong>Infective Endocarditis<\/strong><\/td><td>Higher morbidity<\/td><td>Slightly better salvage potential<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">5. Emerging Trends<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>TAVI vs. SAVR:<\/strong> The expansion of TAVI into lower-risk and younger populations is influencing the initial choice of a surgical bioprosthesis, with many clinicians opting for &#8220;TAVI-friendly&#8221; surgical valves to simplify future transcatheter redo procedures.<\/li>\n\n\n\n<li class=\"\"><strong>On-X Valves:<\/strong> These newer mechanical valves allow for lower INR targets (<strong>1.5\u20132.0<\/strong> for aortic) after the initial three months, potentially reducing the bleeding burden of traditional mechanical options.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The choice between a mechanical and a bioprosthetic valve is increasingly viewed through the lens of &#8220;lifetime management,&#8221; shifting away from a simple age-based binary toward a more nuanced assessment of patient longevity, lifestyle, and the feasibility of future interventions. Current guidelines emphasize shared decision-making, but several objective clinical pillars remain central to the selection [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":66902,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-66900","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prosthetic Valve Choice: A Lifetime Strategy - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prosthetic Valve Choice: A Lifetime Strategy - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"The choice between a mechanical and a bioprosthetic valve is increasingly viewed through the lens of &#8220;lifetime management,&#8221; shifting away from a simple age-based binary toward a more nuanced assessment of patient longevity, lifestyle, and the feasibility of future interventions. Current guidelines emphasize shared decision-making, but several objective clinical pillars remain central to the selection [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-07T08:55:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-07T08:55:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"677\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Prosthetic Valve Choice: A Lifetime Strategy\",\"datePublished\":\"2026-05-07T08:55:18+00:00\",\"dateModified\":\"2026-05-07T08:55:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/\"},\"wordCount\":485,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/\",\"name\":\"Prosthetic Valve Choice: A Lifetime Strategy - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg\",\"datePublished\":\"2026-05-07T08:55:18+00:00\",\"dateModified\":\"2026-05-07T08:55:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg\",\"width\":1200,\"height\":677},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/prosthetic-valve-choice-a-lifetime-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prosthetic Valve Choice: A Lifetime Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prosthetic Valve Choice: A Lifetime Strategy - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/","og_locale":"en_US","og_type":"article","og_title":"Prosthetic Valve Choice: A Lifetime Strategy - All About Cardiovascular System and Disorders","og_description":"The choice between a mechanical and a bioprosthetic valve is increasingly viewed through the lens of &#8220;lifetime management,&#8221; shifting away from a simple age-based binary toward a more nuanced assessment of patient longevity, lifestyle, and the feasibility of future interventions. Current guidelines emphasize shared decision-making, but several objective clinical pillars remain central to the selection [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-05-07T08:55:18+00:00","article_modified_time":"2026-05-07T08:55:20+00:00","og_image":[{"width":1200,"height":677,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Prosthetic Valve Choice: A Lifetime Strategy","datePublished":"2026-05-07T08:55:18+00:00","dateModified":"2026-05-07T08:55:20+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/"},"wordCount":485,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/","url":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/","name":"Prosthetic Valve Choice: A Lifetime Strategy - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg","datePublished":"2026-05-07T08:55:18+00:00","dateModified":"2026-05-07T08:55:20+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Prosthetic-Valve-Choice-A-Lifetime-Strategy.jpg","width":1200,"height":677},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/prosthetic-valve-choice-a-lifetime-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Prosthetic Valve Choice: A Lifetime Strategy"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=66900"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66900\/revisions"}],"predecessor-version":[{"id":66906,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66900\/revisions\/66906"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/66902"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=66900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=66900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=66900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}